Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Burger

Showing results (11-20 of 337) with videos related to

Pageof 34
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|February 5, 2015
[Efavirenz and risk of suicide in HIV patients]David M Burger, Quirijn de Mast, Arnt F A Schellekens
Antiviral Therapy|June 27, 2020
SARS-CoV-2 and HIV protease inhibitors: why lopinavir/ritonavir will not work for COVID-19 infectionElise J Smolders, Lindsey Hm Te Brake, David M Burger
Nederlands Tijdschrift Voor Geneeskunde|July 28, 2022
[CYP3A inhibitors as a pharmacokinetic enhancer: pros and cons of drug interactions]David M Burger, P H van Erp, Rob Ter Heine
AIDS (London, England)|April 10, 2024
Negative impact of a health insurer-mandated de-simplification from a single-tablet regimen to a two-tablet regimenPiter Oosterhof, Matthijs Van Luin, Kees Brinkman, et al.
Current Opinion in Infectious Diseases|April 20, 2002
Pros and cons of therapeutic drug monitoring of antiretroviral agentsDavid M Burger, Rob E Aarnoutse, Patricia W H Hugen
The Journal of Antimicrobial Chemotherapy|November 18, 2021
Dexamethasone is a dose-dependent perpetrator of drug-drug interactions: implications for use in people living with HIVTom G Jacobs, Catia Marzolini, David J Back, et al.
The Journal of Antimicrobial Chemotherapy|February 19, 2008
Stavudine plasma concentrations and lipoatrophyHadewych J M ter Hofstede, Peter P Koopmans, David M Burger
AIDS (London, England)|April 11, 2006
Maintenance of successful ritonavir-boosted indinavir and efavirenz therapy in an HIV-infected patient with tuberculosisMark A Boyd, David M Burger, Praphan Phanuphak, et al.
AIDS (London, England)|October 3, 2020
Pharmacokinetics of tenofovir disoproxyl fumarate/emtricitabine in a client on pre-exposure prophylaxis after a total gastrectomyEveline E Roelofsen, Sieds Wildenbeest, Femke P Mollema, et al.
Clinical Pharmacokinetics|June 20, 2020
Pharmacokinetics and Generic Drug Switching: A Regulator's ViewPieter J Glerum, Cees Neef, David M Burger, et al.
Pageof 34

Showing results (11-20 of 337) with videos related to

Sort By:
Pageof 34
Nederlands Tijdschrift Voor Geneeskunde|February 5, 2015
[Efavirenz and risk of suicide in HIV patients]David M Burger, Quirijn de Mast, Arnt F A Schellekens
Antiviral Therapy|June 27, 2020
SARS-CoV-2 and HIV protease inhibitors: why lopinavir/ritonavir will not work for COVID-19 infectionElise J Smolders, Lindsey Hm Te Brake, David M Burger
Nederlands Tijdschrift Voor Geneeskunde|July 28, 2022
[CYP3A inhibitors as a pharmacokinetic enhancer: pros and cons of drug interactions]David M Burger, P H van Erp, Rob Ter Heine
AIDS (London, England)|April 10, 2024
Negative impact of a health insurer-mandated de-simplification from a single-tablet regimen to a two-tablet regimenPiter Oosterhof, Matthijs Van Luin, Kees Brinkman, et al.
Current Opinion in Infectious Diseases|April 20, 2002
Pros and cons of therapeutic drug monitoring of antiretroviral agentsDavid M Burger, Rob E Aarnoutse, Patricia W H Hugen
The Journal of Antimicrobial Chemotherapy|November 18, 2021
Dexamethasone is a dose-dependent perpetrator of drug-drug interactions: implications for use in people living with HIVTom G Jacobs, Catia Marzolini, David J Back, et al.
The Journal of Antimicrobial Chemotherapy|February 19, 2008
Stavudine plasma concentrations and lipoatrophyHadewych J M ter Hofstede, Peter P Koopmans, David M Burger
AIDS (London, England)|April 11, 2006
Maintenance of successful ritonavir-boosted indinavir and efavirenz therapy in an HIV-infected patient with tuberculosisMark A Boyd, David M Burger, Praphan Phanuphak, et al.
AIDS (London, England)|October 3, 2020
Pharmacokinetics of tenofovir disoproxyl fumarate/emtricitabine in a client on pre-exposure prophylaxis after a total gastrectomyEveline E Roelofsen, Sieds Wildenbeest, Femke P Mollema, et al.
Clinical Pharmacokinetics|June 20, 2020
Pharmacokinetics and Generic Drug Switching: A Regulator's ViewPieter J Glerum, Cees Neef, David M Burger, et al.
Pageof 34